Sample results
HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a chronic neurodegenerative disease that causes progressive inflammation of the spinal cord, resulting in weakness, stiffness, and difficulty walking. It is caused by the Human T-Cell Lymphotropic Virus Type I (HTLV-I), a retrovirus that infects white blood cells and triggers an immune response that damages the spinal cord. The Human T-Cell Lymphotropic Virus I, II (HTLV-I/HTLV-II) Qualitative test is the most important test for diagnosis because it detects the presence of HTLV-I DNA, confirming the underlying viral infection.
HAM/TSP is caused by the Human T-Cell Lymphotropic Virus Type I (HTLV-I), a retrovirus that infects CD4+ T lymphocytes (white blood cells). After infection, the virus can trigger a chronic inflammatory response in the spinal cord, leading to progressive damage of the nerve fibers. While many people infected with HTLV-I remain asymptomatic throughout their lives, approximately 1-2% develop HAM/TSP, typically years or decades after the initial infection. The exact mechanism that causes some infected individuals to develop neurological symptoms while others do not is still being studied, but it involves a combination of viral load, immune response, and genetic factors.
The Human T-Cell Lymphotropic Virus I, II (HTLV-I/HTLV-II) Qualitative test is the most important test for HAM/TSP because it detects the presence of HTLV-I DNA in your blood, confirming the underlying viral infection that causes this condition. This blood test is essential for diagnosis since HAM/TSP cannot develop without HTLV-I infection. A positive HTLV-I result, combined with characteristic neurological symptoms like progressive leg weakness, stiffness, and walking difficulty, helps your healthcare provider make an accurate diagnosis. While the blood test confirms viral infection, your doctor will also perform neurological examinations and may order imaging studies like MRI to assess spinal cord inflammation and rule out other conditions with similar symptoms.
You should get tested if you experience progressive weakness or stiffness in your legs, difficulty walking or maintaining balance, frequent urinary urgency or bladder control problems, or lower back pain that worsens over time. Testing is especially important if you were born in or have lived in areas where HTLV-I is common, such as Japan, the Caribbean, parts of South America, or sub-Saharan Africa. You should also consider testing if you have received blood transfusions before 1988 (when screening began), if you have a sexual partner with known HTLV-I infection, or if your mother had HTLV-I infection (the virus can be transmitted through breastfeeding). Early detection helps your healthcare provider monitor your condition and begin appropriate management to slow disease progression.
What this means
Your test came back negative, meaning no HTLV-I viral DNA was detected in your blood. This is the expected and healthy result, indicating you are not infected with this retrovirus.
Recommended actions
Continue practicing safe sex with barrier protection
Avoid sharing needles or personal items that may contact blood
Consider retesting if you have ongoing risk factors or new exposures
Maintain open communication with healthcare providers about risk factors
Not overhyped or overpriced. Just comprehensive blood testing made simple and for everyone.
Sample results
Your 24/7 Personal Lab Guide
Quick questions: